Form 144 UNITED THERAPEUTICS Corp Filed by: EDGEMOND JAMES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
August 20, 2024 4:53 AM EDTWells Fargo analyst Tiago Fauth raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $380.00 (from $350.00) while maintaining a Overweight rating.
The analyst comments "Thoughts on the stock. We previously modeled Yutrepia launching this year, as the FDA faced no legal hurdles in... More
